FDA Calendar for Javelin Pharmaceuticals Inc. (JAV)

| Register (free)
Javelin Pharmaceuticals, Inc. (Javelin) is a specialty pharmaceutical company. It is engaged in the research, development and commercialization of products for the pain management market. The Company develops products optimized for relieving acute moderate-to-severe pain. In addition, the product choices available for the treatment of acute moderate-to-severe pain are limited in the doses that may be given due to side effects, including cardiovascular depression, tolerance and addiction, respiratory depression, constipation, sedation, and general diminution of quality of life. Javelin’s product candidates Dyloject (injectable diclofenac), Ereska (intranasal ketamine) and Rylomine (intranasal morphine) are focused on treating a variety of pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain, such as orthopedic injury pain, procedural pain and burn pain.

Around The Net


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
Dyloject Pain Management Pending DecisionPhase 3


Events

No future events listed at this time, please check back later.
1 past event(s) found. Click here to view them.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

$0.00
0
1/1/0001 12:00:00 AM

Sponsors

Other Links